US 8080584
Delayed release rasagiline citrate formulation
granted A61KA61K31/135A61K9/2013
Quick answer
US patent 8080584 (Delayed release rasagiline citrate formulation) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 41
- CPC classes
- A61K, A61K31/135, A61K9/2013, A61K9/2018, A61K9/2054